Skip to main content

Low efficacy rates mar China’s COVID diplomacy in Gulf states

After a top Chinese health official acknowledged that the Chinese-produced vaccines have lower efficacy rates, will Gulf states using the product turn to other providers?
Vails are seen on the production line of CoronaVac, Sinovac Biontech's vaccine against COVID-19, at the Butantan biomedical production center on April 23, 2021, in Sao Paulo, Brazil.

While flight suspensions and vaccine-linked travel curbs continue to impact the states of the Gulf Cooperation Council, most of the latter have ramped up their vaccination campaigns. Nearby countries like India are in crisis and the Arab states would like to be risk-free zones.

The vaccine has been made virtually compulsory and, in some states, most leisure activities have been limited to those who have gotten the shot. Upgrading public health security, Abu Dhabi is even mulling measures to restrict the movement of some unvaccinated workers.

Access the Middle East news and analysis you can trust

Join our community of Middle East readers to experience all of Al-Monitor, including 24/7 news, analyses, memos, reports and newsletters.


Only $100 per year.